TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA" or the "Company"), a Phase 3 registration-stage immune-oncology company developing novel technologies to overcome resistance to cancer ...
RSPR Invesco S&P 500 Equal Weight Real Estate ETF ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果